76 related articles for article (PubMed ID: 2800566)
61. Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC.
Battke C; Ruiss R; Welsch U; Wimberger P; Lang S; Jochum S; Zeidler R
Cancer Immunol Immunother; 2011 May; 60(5):639-48. PubMed ID: 21293856
[TBL] [Abstract][Full Text] [Related]
62. CD3zeta expression and T cell proliferation are inhibited by TGF-beta1 and IL-10 in cervical cancer patients.
Díaz-Benítez CE; Navarro-Fuentes KR; Flores-Sosa JA; Juárez-Díaz J; Uribe-Salas FJ; Román-Basaure E; González-Mena LE; Alonso de Ruíz P; López-Estrada G; Lagunas-Martínez A; Bermúdez-Morales VH; Alcocer-González JM; Martínez-Barnetche J; Hernández-Pando R; Rosenstein Y; Moreno J; Madrid-Marina V
J Clin Immunol; 2009 Jul; 29(4):532-44. PubMed ID: 19259799
[TBL] [Abstract][Full Text] [Related]
63. Role of zinc and alpha2 macroglobulin on thymic endocrine activity and on peripheral immune efficiency (natural killer activity and interleukin 2) in cervical carcinoma.
Mocchegiani E; Ciavattini A; Santarelli L; Tibaldi A; Muzzioli M; Bonazzi P; Giacconi R; Fabris N; Garzetti GG
Br J Cancer; 1999 Jan; 79(2):244-50. PubMed ID: 9888464
[TBL] [Abstract][Full Text] [Related]
64. Signaling defects and functional impairment in T-cells from cervical cancer patients.
Cheriyan VT; Krishna SM; Kumar A; Jayaprakash PG; Balaram P
Cancer Biother Radiopharm; 2009 Dec; 24(6):667-73. PubMed ID: 20025546
[TBL] [Abstract][Full Text] [Related]
65. Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman J; Pecorelli S; Cannon M; Parham GP
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):997-1006. PubMed ID: 11072156
[TBL] [Abstract][Full Text] [Related]
66. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
67. NK cell activity in the presence of IL-12 is a prognostic assay to neoadjuvant chemotherapy in cervical cancer.
Cosiski Marana HR; Santana da Silva J; Moreira de Andrade J
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):318-23. PubMed ID: 10985887
[TBL] [Abstract][Full Text] [Related]
68. Circulating immune profile in patients with pre-cancer and cancer of the cervix: a cross sectional study among Indian women.
Gupta MM; Jain R; Parashari A; Singh V; Sharma S
Bull Cancer; 1993 Oct; 80(10):852-6. PubMed ID: 8204922
[TBL] [Abstract][Full Text] [Related]
69. Cell-mediated immunity in patients with invasive carcinoma of the cervix.
Park TK; Kim SN
Yonsei Med J; 1989; 30(2):164-72. PubMed ID: 2800566
[TBL] [Abstract][Full Text] [Related]
70.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
71.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
72.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
73.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
74.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
